News/ News/ R&D Swiss start-up Noema raises $59m to develop neurology drugs offloaded by Roche Richard Staines Biotech, Funding, neurology, Noema, R&D, Roche, Tuberous Sclerosis Complex 0 Comment Swiss biotech Noema has raised 54 million Swiss francs ($59m) to develop four neurological disorder drugs licensed in Share X Swiss start-up Noema raises $59m to develop neurology drugs offloaded by Roche https://pharmaphorum.com/news/swiss-start-up-noema-raises-59m-to-develop-neurology-drugs-offloaded-by-roche/